Artículos del autor

solaci

Coronary disease

Revascularization Using DES in Infrapopliteal Disease: Meta-Analysis and Change of Paradigm?

Peripheral vascular disease (PVD) has been under-studied and under-recognized in comparison with ischemic heart disease and stroke,...
solaci -
Other

EuroPCR 2022 | CLASP TR Study: Promising Results of Endovascular Intervention of Tricuspid Regurgitation

At present, we are well aware of the rise in mortality caused by severe tricuspid regurgitation (TR)....
solaci -
Structural Heart Disease

EuroPCR 2022 | The MITRA TUNE Registry

Left atrial enlargement with or without atrial fibrillation (AF), absence of valvular degeneration, and heart failure with...
solaci -
Institutional News

SOLACI-SOCIME 2022 | Present Your Work at the Congress and Take Your Carrer to the Next Level

The call for scientific research, posters, and oral presentations at the SOLACI-SOCIME 2022 Congress is NOW open. Submit...
solaci -
Institutional News

SOLACI-SOCIME 2022 | The Meeting of Interventional Cardiologists You Cannot Miss

With SOLACI-SOCIME 2022 we got back our space, a unique place for us to learn, catch up...
solaci -
Other

EuroPCR 2022 | Real World Outcomes on Edge-to-Edge Tricuspid Valve Repair: 30 Day Outcomes of the TriClip bRight

This study was carried out to assess the safety and efficacy of the TriClip (edge-to-edge repair) in...
solaci -
Coronary disease

DISCO RADIAL: Conventional or Distal Transradial Access?

Conventional transradial access (TRA) is already established as the access of choice for percutaneous coronary procedures, regardless...
solaci -
Other

EuroPCR 2022 | TriCLASP, Evolution at 30 Days

Tricuspid regurgitation (TR) is difficult to manage and is a mortality predictor. At present, surgery is recommended,...
solaci -